ONCT Wutah pendapatan triwulanan Oncternal Therapeutics

Simbol lan logo merek Oncternal Corp (ONCT)

Oncternal Therapeutics (ONCT) dynamics rely on synergy with oncology centers in the development of CAR-T products. The percentage change in quarterly revenue on the base chart of the GURU.Markets service demonstrates the current trend, where the value of 175.40 shows the latest figure. This is a result of management's efforts regarding the treatment of resistant tumors and the delegation of molecule batch production for lymphomas to certified contract organizations.

Oncternal Corp (ONCT) - Tingkat wutah pendapatan sajrone kuartal saka 04.07.2022 nganti 14.12.2024

Oncternal Therapeutics, Inc. (ONCT) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:
- data dhuwit lan arus kas:
Analisis umum perusahaan:Oncternal Therapeutics Inc (ONCT)
Barang unggulan oncternal.com

Investors view Oncternal Therapeutics (ONCT) as a defensive asset due to the independence of its product cycle from global macroeconomics. By analyzing the quarterly revenue trend, you can observe revenue growth relative to the same period last year, which allows for the rapid determination of business scaling rates and confirms the stability of cash flow within the innovative medicine sector.

Pesaing utama

INCY - Wutah pendapatan kuartal marang kuartal|Owah-owahan pendapatan dibandhingake kuartal kepungkur HUTCHMED (HCM)|NUVB: Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Day One Bio DAWN|Wutah dodolan triwulanan MNPR|Tingkat wutah pendapatan sajrone kuartal Inhibrx Biosciences INBX|Wutah dodolan triwulanan IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Tambahing pendapatan triwulanan|Heron Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan CRBP (Corbus Pharma)|CRDF: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal beyondspringpharma.com (BYSI)|Wutah pendapatan kuartal marang kuartal bioatla.com|LIXT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan CTXR|Wutah pendapatan triwulanan Cellectar Corp (CLRB)|Wutah pendapatan kuartal marang kuartal BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Dinamika pendapatan kuartal marang kuartal|APRE: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal NCNA|CMRX (Chimerix, Inc.) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Tambahing pendapatan triwulanan|KRON - Tingkat wutah pendapatan sajrone kuartal|Kintara Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal PRTG (Portage)